technetium-tc-99m-mebrofenin and Dyspepsia

technetium-tc-99m-mebrofenin has been researched along with Dyspepsia* in 1 studies

Other Studies

1 other study(ies) available for technetium-tc-99m-mebrofenin and Dyspepsia

ArticleYear
The influence of gallbladder function on the symptomatology in gallstone patients, and the outcome after cholecystectomy or expectancy.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:3

    The purpose of this study was to examine whether gallbladder function as assessed by a hepatobiliary scintigraphy was related to the symptomatology in gallstone patients and to the outcome 1 year after either cholecystectomy or watchful waiting. The study included 100 patients with uncomplicated gallstone disease. Fifty-six patients had a functioning gallbladder and 44 had a nonfunctioning gallbladder. Patients with a nonfunctioning gallbladder had significantly more vomiting and received more pain-killing injections during pain attacks. Otherwise, there were no differences in pain patterns or characteristics of dyspeptic symptoms in relation to gallbladder function. In patients with a functioning gallbladder, there were no significant differences between the group of patients with impaired and normal gallbladder function. Cholecystectomy was performed in 69 patients and at the 1-year follow-up; 22% continued to have pain attacks, but this was not related to the gallbladder function preoperatively. In 31 patients without cholecystectomy, 14 patients became asymptomatic within a 1-year follow-up. However, this was not related to gallbladder function. In conclusion, gallbladder function evaluated by a hepatobiliary scintigraphy was not related to the symptoms in gallstone patients, and was not related to the occurrence of symptoms after cholecystectomy or watchful waiting.

    Topics: Abdominal Pain; Adult; Aged; Aniline Compounds; Cholecystectomy; Cholecystolithiasis; Dyspepsia; Female; Glycine; Humans; Imino Acids; Male; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome

2007